文献速递血栓与止血

血友病A女性携带者一期凝血法与显色法FVIII活性检测结果不一致:一项回顾性临床研究

Discrepancy between one-stage clotting and chromogenic factor VIII activity in women with hemophilia A and hemophilia A carriers: a retrospective clinical study.
PubMed 文献 · J Thromb Haemost · 2025-03-06

该研究回顾性纳入2个中心的109例血友病A携带者,比较一期法(OSA)与显色法(CSA)测定的FVIII活性。23%的携带者OSA测得FVIII<40 IU/dL,41%在CSA检测时出现不一致结果,49例报告出血事件,157次妊娠中14例发生产后出血。作者强调两法联用以识别出血高风险女性。

要点

  • 109例血友病A携带者中,23%经OSA测得FVIII<40 IU/dL
  • 41%的携带者在CSA检测时出现结果不一致,20例两法结果不一致
  • 49例报告出血事件,157次妊娠中14例发生产后出血

核心结论

  • 本研究强调OSA与CSA测定的FVIII结果存在显著不一致,对诊断和出血风险评估有影响,并强调需同时使用两种方法以识别出血风险较高的女性,尤其是手术前。

研究设计与样本

  • 回顾性研究,纳入来自2个中心的109例血友病A携带者。

主要发现

  • 23%的携带者经OSA测得FVIII水平<40 IU/dL,41%经CSA检测时出现不一致结果。
  • 血管性血友病因子活性与抗原水平正常,均值分别为84 IU/dL和107。
  • OSA与CSA的FVIII结果存在显著相关性,但20例女性两法结果不一致。
  • 49例报告出血事件,包括18例手术并发症、1例关节出血和30例月经过多,均发生于血管性血友病因子水平正常者。
  • 157次妊娠中观察到14例产后出血,其中3例需输血或手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For every man diagnosed with hemophilia, approximately 1.6 women are expected to be carriers. Carriers are classified based on their factor (F) VIII levels and symptoms, ranging from asymptomatic to mild, either moderate or severe symptoms. Close monitoring is critical for carriers with low FVIII levels or bleeding symptoms, as the bleeding risk is difficult to assess due to inconsistent correlations with routine one-step assay (OSA) measurements. OBJECTIVES: This study hypothesized that the chromogenic FVIII assay (CSA) may provide valuable information for estimating the bleeding risk in some hemophilia carriers. METHODS: This retrospective study included 109 hemophilia A carriers from 2 centers. RESULTS: Among them, 23% had FVIII levels <40 IU/dL when assessed using OSA, while 41% showed discrepancies when assessed using CSA. von Willebrand factor activity and antigen levels were normal, with mean values of 84 IU/dL and 107, respectively. There was a significant correlation between OSA and CSA FVIII results, although 20 women had discordant results between the 2 methods. Bleeding events were reported in 49 women, including 18 surgical complications, 1 joint bleeding episode, and 30 cases of heavy menstrual bleeding, all occurring with normal von Willebrand factor levels. There were 157 pregnancies in which 14 cases of postpartum hemorrhage were observed, 3 of which required transfusion or surgery. CONCLUSION: This study highlights the significant discrepancies between OSA and CSA in FVIII results, with implications for diagnosis and bleeding risk assessment. It emphasizes the need to use both methods to identify women at a higher risk of bleeding, especially before surgery.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Desage S, Lienhart A, Janbain M, et al. Discrepancy between one-stage clotting and chromogenic factor VIII activity in women with hemophilia A and hemophilia A carriers: a retrospective clinical study. J Thromb Haemost. 2025. PMID: 40056988. doi:10.1016/j.jtha.2025.02.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。